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ABSTRACT 22 
Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly spreading and 23 
taking a staggering toll on all healthcare systems, largely due to the dissemination 24 
of genes coding for potent carbapenemases. An important family of 25 
carbapenemases are the Zn(II)-dependent β-lactamases, known as Metallo-β-26 
lactamases (MBLs). Among them, the New-Delhi Metallo-β-lactamase (NDM) has 27 
experienced the fastest and widest geographical spread. While other clinically 28 
important MBLs are soluble periplasmic enzymes, NDM β-lactamases are 29 
lipoproteins anchored to the outer membrane in Gram-negative bacteria. This 30 
unique cellular localization endows NDM with an enhanced stability upon the Zn(II) 31 
starvation elicited by the immune system response in the sites of infection. Since 32 
the first report of NDM-1 β-lactamase, new allelic variants (16 in total) have been 33 
identified in clinical isolates, differing by a limited number of substitutions. Here we 34 
show that these variants have evolved by accumulating mutations that enhance 35 
their stability or the Zn(II) binding affinity in vivo, overriding the most common 36 
evolutionary pressure acting on catalytic efficiency. We identified the ubiquitous 37 
mutation M154L as responsible of improving the Zn(II) binding capabilities of the 38 
NDM variants. These results also reveal that Zn(II) deprivation imposes a strict 39 
constraint in the evolution of this MBL, overriding the most common pressures 40 
acting on catalytic performance, and shed light on possible inhibitory strategies. 41 
 42 
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INTRODUCTION 44 
Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly spreading and 45 
taking a staggering toll on all healthcare systems (1, 2), largely due to the 46 
dissemination of genes coding for potent carbapenemases (3). Metallo-β-47 
lactamases (MBLs) are Zn(II)-dependent enzymes that represent one of the largest 48 
group of carbapenemases. MBLs are able to hydrolyze not only carbapenems, but 49 
also penicillins and cephalosporins with comparable performances (4, 5). They 50 
include the families of plasmid-encoded IMP, VIM and NDM enzymes, which have 51 
disseminated worldwide among opportunistic and pathogenic bacteria. These 52 
enzymes are not affected by the action of serine-β-lactamase inhibitors, including 53 
the newly developed avibactam, and there are not specific inhibitors for MBLs 54 
available in the clinic.  55 
The New-Delhi Metallo-β-lactamase (NDM) has experienced the fastest and 56 
widest geographical (6, 7) spread among MBLs in recent years. The clinical 57 
success of NDM has been attributed to the fact that is a lipoprotein anchored to the 58 
outer membrane in Gram-negative bacteria (Fig. 1B) (8-10). This feature is 59 
exclusive to this enzyme in contrast to all other MBLs, which are soluble 60 
periplasmic proteins (5).  We have recently suggested (9) that this cellular 61 
localization can boost the fitness of NDM-1 under physiological conditions. At the 62 
sites of infection, pathogens must face the “nutritional immunity” response by the 63 
host immune system, which involves the release of large amounts of the metal-64 
chelating protein calprotectin. As a consequence, Zn(II) levels in the bacterial 65 
periplasm decrease, leading to accumulation of apo (non-metallated) MBLs, that 66 
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are susceptible to proteolytic degradation (9). Membrane anchoring prevents 67 
degradation of apo-NDM-1 upon this Zn(II) starvation process (9).  68 
Since the first report of NDM-1 (11), new allelic variants (16 in total) have 69 
been identified in clinical isolates, differing by a limited number of substitutions 70 
(12). The 16 NDM variants are characterized by substitutions at a relatively small 71 
number of positions, all occurring outside the active site (Fig. 1). Residue M154 is 72 
the most frequently substituted, with M154L being the most common change 73 
(found in the single mutant NDM-4 and in six double mutants: NDM-5, NDM-7, 74 
NDM-8, NDM-12, NDM-13 and NDM-15), and one occurrence of M154V (in NDM-75 
11). Residue D130 is replaced in 3 alleles, with substitutions D130G (NDM-8 and 76 
NDM-14) and D130N (NDM-7). Substitutions D95N and A233V are present in two 77 
alleles each, both as single variants (NDM-3 and NDM-6) and in combination with 78 
M154L (NDM-13 and NDM-15) (Fig. 1A). However, comparative studies of MBL 79 
proteins NDM 1-8 have not revealed significant differences in their resistance 80 
profiles nor in the in vitro activities of the purified, soluble forms of these enzymes 81 
(with truncated lipidation sites) (13). These observations cannot account for the 82 
selection of these alleles in clinical environments.  83 
We contend that the expression of NDM variants should be evaluated in 84 
conditions as close as possible to the physiological ones: (1) in the membrane-85 
bound form, and (2) under environmental conditions of Zn(II) deprivation (9, 14, 86 
15). Here we examine the resistance profiles of the different NDM variants under 87 
these conditions, identify the molecular features responsible for the observed 88 
phenotypes, and demonstrate that NDM variants are evolving by enhancing their 89 
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Zn(II) binding capability in vivo. These results also reveal that Zn(II) deprivation has 90 
imposed a strict constraint in the evolution of this MBL, overriding the most 91 
common pressures acting on catalytic performance, and shed light on possible 92 
inhibitory strategies.  93 
RESULTS 94 
To compare the performance of NDM variants within a common 95 
physiological background, we expressed the blaNDM genes coding for all 16 alleles 96 
in an isogenic E. coli strain with their native signal peptide, targeting the variants to 97 
the outer membrane with expression levels similar to those observed in clinical 98 
strains (9, 16). To ensure homogeneous immunodetection and quantitation, all 99 
variants were expressed fused to a common C-terminal Strep-tag, which does not 100 
affect resistance (9). Expression of blaNDM alleles resulted in similar protein levels, 101 
except for NDM-10 (harboring 5 substitutions), displaying a 5-fold reduction with 102 
respect to NDM-1 (Fig. S1). In the case of NDM-2, carrying mutation P28A, 20% of 103 
the total protein was found as a soluble, non-lipidated periplasmic lactamase, 104 
indicating that mutations proximal to the lipidation site (C26) can affect membrane 105 
anchoring.  106 
In these constructs, minimum inhibitory concentrations (MICs) of piperacillin 107 
(PIP), cefepime (FEP), cefotaxime (CTX) and imipenem (IPM) for most variants did 108 
not reveal major differences among blaNDM alleles (Table S1), except for blaNDM-10. 109 
This quintuple mutant displayed significantly lower MIC values, that we attribute to 110 
the lower protein levels of this variant. Overall, these resistance profiles do not 111 
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differ from those reported for alleles blaNDM 1-8 (13). However, the experimental 112 
conditions employed to study the resistance profile may not always reflect the 113 
actual environment that is acting in selection (17). For instance, the standard 114 
conditions used for MIC determinations involve media with high Zn(II) content that 115 
do not represent the environment at infection sites, where potent metal-116 
sequestering proteins such as calprotectin (CP) are released by the host immune 117 
system (10, 18-21). We therefore evaluated the impact of Zn(II) deprivation in MIC 118 
values by adding the chelating agent dipicolinic acid (DPA) to the medium. It has 119 
already been shown that DPA can mimic the effect elicited by the action of CP, 120 
without being lethal for bacteria (9).  121 
These experiments (summarized in Fig. 2) revealed that: (1) MIC values 122 
were affected by addition of DPA; and (2) the response was strongly allele-123 
dependent. In general, the impact of Zn(II) deprivation on MIC values was 124 
noticeable at DPA levels higher than 350 µM (Fig. 2 and Table S2). Most NDM 125 
variants granted higher MIC values than NDM-1 at DPA levels beyond this value. 126 
NDM-10 was an exception, since resistance levels for this variant were drastically 127 
abolished at low concentrations of DPA. These results clearly show that the amino 128 
acid substitutions have a defined and distinct impact in the ability to endure Zn(II) 129 
starvation.  130 
NDM variants can be classified into four groups according to the 131 
dependence of resistance on DPA concentration. Tier 1 alleles are those 132 
displaying the highest tolerance to Zn(II) scarcity: NDM-15 (M154L A233V), NDM-133 
13 (D95N M154L), NDM-12 (M154L G222D), NDM-8 (D130G, M154L), NDM-7 134 
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(D130N M154L), and NDM-5 (V88L M154L). Tier 2 alleles possess greater 135 
tolerance to Zn(II) starvation than NDM-1, with MICs at least one 2-fold dilution 136 
below the lowest of Tier 1 variants. Tier 2 includes NDM-14 (D130G), NDM-9 137 
(E152K), NDM-6 (A233V), NDM-4 (M154L) and NDM-3 (D95N). Tier 3 MBLs 138 
behave similarly to NDM-1, and includes NDM-16 (R264H), NDM-11 (M154V), 139 
NDM-2 (P28A) and NDM-1. Finally, Tier 4 contains NDM-10, the only allele that 140 
performs worse than NDM-1.  141 
Tier 1 consists of double mutants while Tier 2 contains only single mutants, 142 
indicating that variants with two mutations possess a higher ability to confer 143 
resistance under low Zn(II) conditions. This observation suggests that tolerance to 144 
Zn(II) starvation is selected as mutations accumulate during the evolution of NDM. 145 
Furthermore, all Tier 1 variants possess substitution M154L, which seems crucial 146 
for adaptation to low Zn(II) availability. This enhancement can in principle be 147 
attributed to the specific presence of a leucine residue in position 154, since NDM-148 
11 (M154V) displays a behavior similar to NDM-1 upon addition of DPA (Fig. 2). 149 
We interrogated the role of residue 154 by performing site-saturation 150 
mutagenesis on NDM-1 at this position. MIC values of cefotaxime were within one 151 
dilution of NDM-1 for seven out of the nineteen mutants, revealing that position 154 152 
is highly tolerant to substitutions (Table S3), in agreement with its location near the 153 
protein surface (Fig. 1B). In the presence of DPA, however, only variant M154L 154 
(NDM-4) provided higher levels of resistance than NDM-1 upon Zn(II) starvation, 155 
while all others were more susceptible (Fig. S2). The selection of replacement 156 
M154L in a position highly tolerant to mutations strongly suggests that Zn(II) 157 
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deprivation has exerted a significant evolutionary pressure in the natural selection 158 
of NDM alleles.  159 
We next aimed to characterize the molecular features giving rise to these 160 
phenotypes. Zn(II) starvation elicits degradation of MBLs within the periplasmic 161 
space, since the apo-enzymes (Zn(II)-free forms) are susceptible to proteolysis 162 
while the metal-bound proteins are stable (9). We interrogated the in vivo stability 163 
of NDM alleles upon Zn(II) depletion by monitoring the time evolution of the NDM 164 
protein levels in E. coli cells after addition of DPA to the growth medium (Fig. S3). 165 
Under these conditions, NDM-1 experienced >90% degradation within 60 minutes, 166 
with a half-life of ca. 9 minutes. Degradation rates were highly variable among 167 
NDM alleles, with half-lives spanning from 2 to 75 min (Fig. 3). Most variants 168 
performed better or similar to NDM-1. 169 
The NDM variants can be classified into four groups according to their 170 
stability profiles: (1) proteins with an enhanced stability against degradation (t1/2 171 
between 75 and 53 min): NDM-15 (M154L A233V), NDM-6 (A233V) and NDM-9 172 
(E152K); (2) proteins more stable than NDM-1 (t1/2 between 20 and 17 min): NMD-173 
5 NDM-7 (D130N M154L), NDM-12 (M154L G222D) and NDM-13 (D95N M154L); 174 
(3) proteins with a stability similar to NDM-1 (t1/2 between 13 and 8 min): NDM-2 175 
(P28A), NDM-3 (D130G), NDM-4 (M154L), NDM-11 (M154V) and NDM-16 176 
(R264H); and (4) proteins with a markedly lower stability than NDM-1 (t1/2 < 2 min): 177 
NDM-10. Analysis of these data reveals that most double variants exhibited a 178 
greater stability than NDM-1, except NDM-8 (M154L D130G) which was 179 
comparable to NDM-1. Among point mutations present in NDM alleles, 180 
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substitutions A233V and E152K were shown to be stabilizing, giving rise to the only 181 
single variants displaying high stability: NDM-6 and NDM-9. The most stable NDM 182 
mutants (groups 1 and 2) outperform even SPM-1, that was previously shown to be 183 
the most stable MBL upon metal depletion under conditions similar to those 184 
reported here (Figs. S4 and S5) (9, 15). 185 
We next analyzed possible epistatic interactions between mutations. NDM-186 
15 (M154L A233V) shows a degradation profile similar to the single mutant NDM-6, 187 
suggesting that its high stability is mostly due to mutation A233V, while the 188 
stabilizing role of M154L is minor. A comparable stabilizing effect by mutation 189 
M154L is observed when comparing NDM-4 with NDM-1. Variant NDM-13 (D95N 190 
M154L) is more stable than the corresponding single mutants NDM-3 (D95N) and 191 
NDM-4 (M154L), and both mutations may contribute to the increased stability. 192 
NDM-8 (D130G M154L) is as stable as NDM-4, and thus D130G does not appear 193 
to significantly contribute to stability. We conclude that the effects of the different 194 
mutations on the stability are additive, with no evident epistatic interactions.   195 
The degradation profiles upon Zn(II) starvation do not account for the 196 
resistance provided by the alleles under these conditions: NDM-4 (M154L) and 197 
NDM-11 (M154V) are degraded at a similar rate than NDM-1 (Fig. 3), but NDM-4 198 
provides higher levels of resistance under Zn(II) deprivation (Fig. 2). Conversely, 199 
NDM-6 (A233V) and NDM-15 (M154L A233V) show similar high stabilities, but 200 
NDM-15 outperforms NDM-6 under Zn(II) starvation (Fig. 2). These observations, 201 
together with the presence of mutation M154L in all Tier 1 mutants, reveal that 202 
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M154L enhances resistance upon Zn(II) limiting conditions without imparting 203 
protein stabilization.  204 
Resistance at low Zn(II) levels can be optimized by two main mechanisms: 205 
(1) improved stability of the apo-proteins or (2) optimization of the Zn(II) binding 206 
affinity in the different variants, so that the accumulation of apo-proteins is 207 
minimized. Thus, we evaluated the impact of positions 154 and 233 in the metal 208 
binding affinity of variants NDM-1, NDM-4, NDM-6, NDM-11 and NDM-15, which 209 
present mutations in these positions. To assess this property, we measured the β-210 
lactamase activity of these enzymes in spheroplasts containing the membrane-211 
bound forms challenged with DPA. Studies on spheroplasts allow direct 212 
assessment of the enzymatic activity, being devoid of periplasmic proteases that 213 
elicit protein degradation. In all cases, we observed a decrease in activity (Fig. 4) 214 
with increasing concentrations of DPA. Immunoblotting experiments revealed 215 
similar protein levels under these conditions (Fig. S6), showing that the decrease in 216 
activity is not due to protein degradation, and therefore can be attributed to 217 
accumulation of the inactive apo-proteins generated by the chelating agent. Thus, 218 
the different behaviors of the alleles (Fig. 4) provide an estimate of the Zn(II) 219 
affinity of each variant. NDM-4 (M154L) and NDM-15 (M154L A233V) displayed 220 
the lowest susceptibility to inactivation by DPA, revealing that mutation M154L 221 
indeed increases the metal binding ability, while the stabilizing mutation A233V 222 
does not. Mutation M154V did not affect Zn(II) binding, in agreement with the 223 
resistance profile observed for NDM-11 (Fig. 2). NDM-6 presented a similar 224 
apparent affinity towards Zn(II) compared to NDM-1, confirming that mutation 225 
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A233V only impacts on the protein stability. This experiment allows us to propose 226 
that the most frequent mutation (M154L) plays a crucial role in NDM fitness by 227 
increasing the Zn(II) binding affinity.  228 
Finally, we sought to directly compare the fitness of NDM alleles under 229 
varying conditions of Zn(II) availability. To this end, we performed competition 230 
experiments between E. coli cells expressing NDM-1, NDM-4, NDM-6 or NDM-15, 231 
in presence of different concentrations of cefotaxime, and with or without addition 232 
of metal chelators to the growth medium (Fig. 5). Both NDM-1 and single mutants 233 
NDM-4 and NDM-6 displayed similar fitness in Zn(II)-rich conditions, i.e. growth 234 
media not supplemented with DPA, and no allele seemed to be favored over the 235 
other within the range of antibiotic concentrations tested (Fig. 5-A and B). In 236 
contrast, NDM-1 and NDM-4 were selected over the double mutant NDM-15, 237 
particularly at higher antibiotic concentrations (Fig. 5-C and D), in accordance with 238 
their slightly higher MICs for CTX (128 vs 64-128 µg/mL). Competition experiments 239 
carried out in presence of 250 µM DPA presented a radically different scenario. 240 
Single mutants NDM-4 and NDM-6 were selected over NDM-1, and NDM-4 was 241 
outcompeted by NDM-15. The double mutant was able to outperform NDM-1 more 242 
effectively than single mutant variants, highlighting the gain in fitness due to 243 
accumulation of beneficial mutations. Finally, we performed competition 244 
experiments between NDM-1 and NDM-15 in the presence of calprotectin (Fig. 245 
5D), obtaining results comparable to those with DPA. Thus, a similar differential 246 
fitness is observed when trying to reproduce metal depletion by the host’s 247 
nutritional immunity response upon pathogenesis. The concentration of CP used 248 
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for the experiment (250 µg/mL) is within physiological range, since levels of up to 249 
1000 µg/mL have been reported in infection sites (20). These competition 250 
experiments clearly reveal that alleles with better Zn(II) binding capability can 251 
outcompete NDM-1 under these conditions, even at antibiotic concentrations well 252 
below the MICs. 253 
 254 
DISCUSSION 255 
Assessment of the molecular features involved during the evolution of 256 
resistance requires recreating as closely as possible the environmental conditions 257 
that may have driven adaptation. For example, study of the evolution of the serine-258 
β-lactamase TEM at sub-lethal antibiotic concentrations, such as those present in 259 
the environment, allowed an exhaustive exploration of the adaptive landscapes of 260 
this protein, leading to increased diversity of this enzyme (17). Here we consider 261 
that, during an infection, the host’s immune system releases metal-chelating 262 
proteins to inhibit the growth of bacteria, which in turn compete for these essential 263 
nutrients by producing high affinity metal importers. In this context, MBLs should 264 
possess optimized Zn(II) binding capabilities to effectively mediate β-lactam 265 
resistance. In particular, clinically relevant MBLs require binding of two Zn(II) ions 266 
in the periplasm to confer resistance (22). The requirements for Zn(II) binding are 267 
stringent, since metal depletion leads to protein degradation, and loss of resistance 268 
is more dramatic. Here we show that the resistance profiles of the known NDM 269 
variants are similar when measured in Zn(II)-rich medium. Instead, significant 270 
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differences appear under Zn(II) deprivation conditions. We further show that most 271 
variants are better suited to resist these conditions than NDM-1.  272 
Our results suggest that the pathways along which NDM alleles are currently 273 
evolving in clinical settings enhance the performance of these enzymes under low 274 
Zn(II) availability. We identified two mechanisms behind this adaptation: a) 275 
stabilization of otherwise unstable apo-enzymes, and b) enhancement of the Zn(II) 276 
affinity to maintain high levels of the active species. Substitutions A233V and 277 
E152K dramatically increase protein stability in the periplasm, while the highly 278 
frequent mutation M154L enhances metal affinity. Both mechanisms can act 279 
independently or combine without epistatic interactions to render enzymes with a 280 
higher fitness under Zn(II) deprivation conditions (NDM-15). A small group of NDM 281 
alleles (NDM-2, NDM-11 and NDM-16) did not show any advantages compared to 282 
NDM-1 in our conditions. The mutations present in these variants may be neutral, 283 
or be the result of a host specific adaptation as previously shown for SPM-1 (15), 284 
that may not be evident in E. coli (e.g. NDM-2 has been only detected in 285 
Acinetobacter baumanii) (12). 286 
A recent work has revealed that evolution of the serine-β-lactamase TEM 287 
has been shaped by optimization of the enzymatic efficiency (23), and not by 288 
stabilization of the protein itself. Our results show that the adaptive landscape of 289 
the metallo-β-lactamase NDM has been shaped by Zn(II) deprivation conditions, 290 
leading to optimization of cofactor binding. In this regard, the identification of the 291 
ubiquitous mutation M154L as responsible of increasing the Zn(II) binding affinity in 292 
different alleles also provides a unique example of optimization of cofactor 293 
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assembly along evolution. This finding is in line with the reconstruction of the 294 
evolutionary trajectory of an in vitro evolved MBL, that disclosed that the Zn(II) 295 
binding affinity may be an essential feature in defining its fitness landscape (13). 296 
Membrane localization is conserved among all NDM alleles, in contrast to 297 
serine-β-lactamases which have in most cases foregone their membrane 298 
anchoring during evolution from Penicillin Binding Proteins (PBPs) (24). This 299 
contrast may be caused by the different fitness effects of membrane anchoring in 300 
each class of enzyme, which ultimately impacts its evolutive fixation. It has been 301 
shown that TEM is functional when anchored to the outer leaflet of the inner 302 
membrane as its PBP predecessors, conferring the same resistance levels as the 303 
native soluble protein without an apparent fitness advantage (24). Meanwhile, we 304 
have previously shown that membrane anchoring of NDM-1 allows it to better 305 
tolerate Zn(II) deprivation conditions (9), as soluble variants of the enzyme are less 306 
stable and confer lower levels of resistance in low Zn(II) environments. The role of 307 
membrane anchoring in stabilization would guarantee the conservation of this 308 
characteristic. It should be noted that anchoring is but one mechanism accessible 309 
to MBLs to improve stability under these conditions, as other MBLs such as SPM-1 310 
or NDM variants carrying the A233V or E152K mutations also possess enhanced 311 
stability against proteolytic degradation.  312 
 Despite the lack of clinically useful inhibitors, recent research has shown 313 
that MBLs may also be challenged by compounds such as Aspergillomarasmine A 314 
(AMA) (25), a Zn(II) chelator able to reverse resistance mediated by MBLs in 315 
animal models. While NDM-1 was susceptible to inactivation by this compound, 316 
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SPM-1 proved to be refractory (25). Our results show that NDMs are evolving 317 
beyond the AMA-resistant SPM-1 MBL, indicating that tolerance to low Zn(II) 318 
availability will undoubtedly allow MBLs to circumvent this type of inhibition. This 319 
stresses the need to develop specifically tailored inhibitors not dependent on metal 320 
chelation to combat the growing threat posed by these enzymes.    321 
  322 
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MATERIALS AND METHODS 323 
Bacterial strains and reagents 324 
Escherichia coli DH5α was used for expression of plasmid pMBLe, microbiological 325 
and biochemical studies. Unless otherwise noted, all strains were grown 326 
aerobically at 37 °C in lysogeny broth (LB) medium supplemented with gentamicin 327 
20 μg/mL when necessary. Chemical reagents were purchased from Sigma-328 
Aldrich, molecular biology enzymes from Promega, and primers from Invitrogen.  329 
 330 
Construction of NDM alleles 331 
blaNDM variants genes were generated from pMBLe-blaNDM-1 (9), which contains the 332 
full-length blaNDM-1 gene fused to a C-terminal Strep-Tag II sequence under control 333 
of an IPTG-inducible pTac promoter. Variants were constructed by site-directed 334 
mutagenesis as previously described (14) using the primers detailed in Table S4. 335 
All constructs were verified by DNA sequencing (University of Maine, USA). 336 
 337 
Periplasm and spheroplasts preparations 338 
Extraction of periplasmic proteins was performed as previously described (9). 339 
Briefly, 2–3 mL of E. coli pMBLe-blaNDM cultures were pelleted and cells were 340 
washed once with 20 mM Tris, 150 mM NaCl, pH 8.0. The washed cells were 341 
resuspended in 20 mM Tris, 0.1 mM EDTA, 20% w/v sucrose, 1 mg/mL lysozyme 342 
(from chicken egg white, Sigma-Aldrich, protein ≥90%), 0.5 mM PMSF, pH 8 343 
(resuspension volume was normalized according to the formula V = 100 μL x 344 
OD600 x Vc, where Vc is the starting volume of culture sample), incubated with 345 
gentle agitation at 4ºC for 30 min, and finally pelleted, with the periplasmic extract 346 
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in the supernatant. The pellet consisting of spheroplasts was washed in 20 mM 347 
Tris, 20% w/v sucrose, pH 8 and resuspended in the same volume of this buffer. 348 
 349 
MBL detection  350 
MBL protein levels were determined by SDS-PAGE followed by Western blot with 351 
Strep-Tag® II monoclonal antibodies (at 1:1000 dilution from 200 μg/ml solution) 352 
(Novagen) and immunoglobulin G-alkaline phosphatase conjugates (at 1:3000 353 
dilution). Protein band intensities were quantified from PVDF membranes with 354 
ImageJ software (26) and converted to relative protein amounts through a 355 
calibration curve constructed under the same experimental conditions. In all cases, 356 
Western blots with antibodies detecting GroEL were performed as loading controls. 357 
 358 
Minimum inhibitory concentration (MIC) determinations 359 
Cefotaxime, cefepime, piperacillin and imipenem MIC determinations were 360 
performed in LB medium using the agar macrodilution method according to CLSI 361 
guidelines (27). In order to measure the effect of Zn(II) availability on antibiotic 362 
resistance, the growth medium was supplemented with varying concentrations of 363 
the metal chelator dipicolinic acid (DPA) (Merck, >98%). In all cases, blaNDM 364 
expression was induced with 100 μM IPTG.  365 
Relative MICs as plotted in Figures 2 and Figure S2 were calculated as (MICNDM – 366 
MICcontrol)/(MICNDM + 0 μM DPA – MICcontrol + 0 μM DPA), where MICNDM and MICcontrol refer 367 
to values measured for E. coli DH5α pMBLe-blaNDM or pMBLe, respectively, under 368 
each set of conditions, and MICNDM + 0μM DPA and MICcontrol + 0μM DPA, the 369 
corresponding values in media without addition of DPA. 370 
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 371 
Effect of external Zn(II) depletion in MBL protein levels  372 
E. coli pMBLe-blaNDM cells were grown at 37ºC up to an OD600 of 0.4. MBL 373 
expression was induced by the addition of 100 μM IPTG, and growth was 374 
continued at 37ºC for 2 h. At this time, cultures were divided in two equal parts. 375 
One portion was treated with 500 μM DPA and the other kept as an untreated 376 
control, and both cultures were grown at 37ºC. Aliquots of DPA-treated and 377 
untreated cultures were taken at different time intervals after DPA addition: 0, 10, 378 
30 and 60 min, and processed for immunodetection. Protein values in DPA-treated 379 
samples were reported relative to the corresponding values in untreated samples. 380 
 381 
Competition experiments 382 
Isogenic E. coli W3110(28) and E. coli W3110 ΔlacZ (29) strains were transformed 383 
with pMBLe-blaNDM-15, pMBLe-blaNDM-6, pMBLe-blaNDM-4 and pMBLe-blaNDM-1. Pairs 384 
of strains expressing different NDM alelles in opposite Lac phenotype backgrounds 385 
(e.g. E. coli W3110 pMBLe-blaNDM-1 and E. coli W3110 ΔlacZ pMBLe-blaNDM-4) 386 
were grown at 37ºC.  387 
Cultures were then diluted 1/100 in fresh LB broth, and grown at 37°C to OD600nm = 388 
0.6. Equal amounts (according to OD600nm) of Lac
- cells expressing one allele and 389 
Lac+ cells producing the competing allele were mixed and diluted 1/500 in fresh LB 390 
broth, supplemented with 20 µg/mL gentamycin, 100 µM IPTG, different 391 
concentrations of cefotaxime, and either with or without addition of 250 µM DPA or 392 
250 µg/mL CP. The greatest concentration of cefotaxime used was the maximum 393 
allowing visible growth under each condition. The competition was then carried out 394 
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by growing the cells ON at 37°C, after which ca. 100-300 cells were plated in LB-395 
agar plates supplemented with 60 µg/mL X-Gal and 100 µM IPTG, and grown ON 396 
at 37°C. Blue and white colonies were counted to determine the proportion of Lac+ 397 
and Lac- cells, and thus of each variant, in the population after the competition. In 398 
order to ensure there was no effect on fitness due to the Lac+/- background, the 399 
experiments were repeated inverting the strains carrying each allele. 400 
 401 
Determination of Zn(II) affinity in spheroplasts 402 
Spheroplasts from E. coli cells expressing NDM variants were centrifuged and 403 
resuspended in Chelex-100-treated HEPES 10 mM, NaCl 200mM, pH 7.5. 404 
Spheroplasts were diluted 1/50 in Chelex-100-treated HEPES 10 mM, NaCl 405 
200mM, pH 7.5 with variable amounts of DPA (0-50 μM). After incubation at 30ºC 406 
for 10 min, 550 μM imipenem was added and β-Lactamase activity measured in a 407 
JASCO V-670 spectrophotometer at 30ºC. Imipenem hydrolysis was monitored at 408 
300 nm (Δε300nm = –9,000 M
–1cm–1).  409 
 410 
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FIGURE LEGENDS 513 
Figure 1. NDM alleles possess a limited number of substitutions located 514 
outside the active site. A, NDM variants and their corresponding mutations with 515 
respect to NDM-1. Substitutions occurring in two or more alleles are indicated in 516 
bold. B, Diagram showing the cellular localization of NDM-1 within the inner leaflet 517 
of the outer membrane in Gram-negative bacteria and crystal structure of NDM-1 518 
(PDB: 4EYL), displaying the residues mutated in clinical alleles (spheres). Spheres 519 
are colored with a gradient from white to black according to increasing frequency of 520 
mutation at that position among alleles. Active site Zn(II) ions are indicated as 521 
green spheres, and residues acting as metal ligands are displayed as sticks. 522 
 523 
Figure 2. NDM alleles display an increased tolerance to Zn(II) starvation with 524 
respect to NDM-1. Cefotaxime MICs for E. coli DH5α cells expressing different 525 
NDM alleles in growth medium supplemented with the indicated concentrations of 526 
DPA, relative to the MIC in 0 μM of DPA. Data corresponds to three independent 527 
experiments, and is presented as mean ± s.e.m. 528 
 529 
Figure 3. Clinical NDM variants possess enhanced in vivo stability upon 530 
Zn(II) starvation. A, MBL protein levels for NDM alleles in whole E. coli cells 531 
quantified from western blots (Figure S3) as a function of time after addition of 500 532 
μM DPA, normalized to control samples not treated with DPA.  Data are presented 533 
as percentage of initial protein remaining after treatment with DPA, and correspond 534 
 o
n
 O
ctober 17, 2017 by G
AZI UNIVERSITESI
http://aac.asm
.org/
D
ow
nloaded from
 
27 
 
to mean ± s.e.m. of three independent experiments. Data points for each allele 535 
were fitted to a first-order exponential decay, indicated as continuous curves. B, 536 
Half-lives for NDM alleles, obtained from exponential decay fit of data in panel A.  537 
 538 
Figure 4. Substitution M154L leads to an increased Zn(II) binding affinity. 539 
Relative β-lactamase activity of spheroplasts from E.coli cells expressing NDM 540 
alleles, after incubation for 10 min at 30ºC with different concentrations of DPA. 541 
Values are presented as relative to activity at 0 µM DPA. Data corresponds to 542 
three independent experiments, and is plotted as mean ± s.e.m.  543 
 544 
Figure 5. NDM alleles outcompete NDM-1 under Zn(II) limiting conditions. 545 
Competition experiments between E. coli W3110 cells expressing NDM alleles in 546 
presence of increasing concentrations of cefotaxime, in growth media with and 547 
without supplementation with metal chelators. A) NDM-1 vs NDM-4. B) NDM-1 vs 548 
NDM-6. C) NDM-4 vs NDM-15. D) NDM-1 vs NDM-15. Data are presented as 549 
mean ± s.e.m. of two independent determinations inverting the Lac+/Lac- 550 
background of the strain carrying each allele. 551 
 552 
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